HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Lin Selected Research

steroid receptor RNA activator

1/2017Silencing of SRA1 Regulates ER Expression and Attenuates the Growth of Stromal Cells in Ovarian Endometriosis.
6/2014Increased steroid receptor RNA activator protein (SRAP) accompanied by decreased estrogen receptor-beta (ER-β) levels during the malignant transformation of endometriosis associated ovarian clear cell carcinoma.
2/2014Influence of ovarian endometrioma on expression of steroid receptor RNA activator, estrogen receptors, vascular endothelial growth factor, and thrombospondin 1 in the surrounding ovarian tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Lin Research Topics

Disease

210Neoplasms (Cancer)
09/2022 - 02/2003
36Endometriosis
07/2021 - 05/2003
22Neoplasm Metastasis (Metastasis)
01/2022 - 05/2007
18Breast Neoplasms (Breast Cancer)
10/2022 - 03/2007
17Hypoxia (Hypoxemia)
03/2022 - 11/2012
16Carcinoma (Carcinomatosis)
06/2022 - 03/2003
12Infections
01/2022 - 01/2013
10Inflammation (Inflammations)
10/2022 - 11/2009
9Hyperthermia
06/2022 - 12/2017
9Pain (Aches)
01/2021 - 11/2009
9Carcinogenesis
09/2020 - 05/2007
8Fibrosis (Cirrhosis)
06/2022 - 06/2008
8Wounds and Injuries (Trauma)
05/2022 - 10/2013
8Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 06/2003
7Starvation
01/2022 - 08/2012
7Glioma (Gliomas)
01/2022 - 03/2006
7COVID-19
12/2021 - 01/2020
7Stomach Neoplasms (Stomach Cancer)
09/2020 - 01/2012
7Obesity
04/2019 - 01/2011
6Hepatocellular Carcinoma (Hepatoma)
01/2021 - 07/2012
6Body Weight (Weight, Body)
01/2021 - 04/2004
6Colonic Neoplasms (Colon Cancer)
12/2020 - 04/2014
6Leukemia
08/2014 - 09/2003
5Myocardial Infarction
01/2022 - 06/2008
5Postoperative Nausea and Vomiting (PONV)
01/2022 - 02/2013
5Bacterial Infections (Bacterial Infection)
01/2021 - 01/2012
5Insulin Resistance
12/2020 - 07/2015
5Ovarian Neoplasms (Ovarian Cancer)
11/2019 - 03/2012
5Diarrhea
07/2019 - 03/2013
4Osteolysis
03/2022 - 11/2020
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2022 - 03/2016
4Rheumatoid Arthritis
12/2021 - 12/2014
4Disease Progression
10/2021 - 01/2020
4Hypertension (High Blood Pressure)
03/2021 - 06/2008

Drug/Important Bio-Agent (IBA)

40Pharmaceutical PreparationsIBA
05/2022 - 05/2011
38Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2008
201-phenyl-3,3-dimethyltriazene (PDT)IBA
03/2022 - 03/2015
17Biological ProductsIBA
06/2022 - 08/2012
16Messenger RNA (mRNA)IBA
10/2022 - 08/2010
16Doxorubicin (Adriamycin)FDA LinkGeneric
03/2022 - 12/2011
14Anti-Bacterial Agents (Antibiotics)IBA
06/2021 - 07/2002
13MicroRNAs (MicroRNA)IBA
01/2022 - 08/2011
13Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 03/2015
12Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2013
12Cisplatin (Platino)FDA LinkGeneric
07/2019 - 07/2003
10CytokinesIBA
02/2022 - 08/2013
10Glutathione (Reduced Glutathione)IBA
01/2022 - 01/2017
10EnzymesIBA
01/2022 - 01/2005
9Estrogen ReceptorsIBA
06/2022 - 02/2014
9AntigensIBA
10/2021 - 03/2013
9Small Interfering RNA (siRNA)IBA
11/2020 - 03/2007
9ProdrugsIBA
11/2018 - 12/2013
8Photosensitizing Agents (Photosensitizers)IBA
02/2022 - 03/2015
8RNA (Ribonucleic Acid)IBA
01/2022 - 01/2017
8DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2003
8PolymersIBA
03/2021 - 05/2015
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2020 - 09/2007
8Silicon Dioxide (Silica)FDA LinkGeneric
12/2019 - 02/2013
8PlatinumIBA
07/2019 - 07/2003
8Mechanistic Target of Rapamycin Complex 1IBA
01/2017 - 08/2012
7Estrogens (Estrogen)FDA Link
06/2022 - 08/2012
7AcidsIBA
03/2022 - 12/2010
7Local AnestheticsIBA
01/2022 - 01/2013
7Oxygen (Dioxygen)IBA
12/2021 - 03/2019
7Therapeutic UsesIBA
06/2021 - 07/2016
7Peptides (Polypeptides)IBA
03/2021 - 07/2004
7Drug CarriersIBA
02/2020 - 02/2013
7Phosphotransferases (Kinase)IBA
10/2019 - 08/2012
6Indicators and Reagents (Reagents)IBA
10/2022 - 04/2014
6VaccinesIBA
09/2022 - 12/2009
6CatalaseIBA
03/2022 - 12/2019
6Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
03/2022 - 12/2019
6Anesthetics (Anesthetic Agents)IBA
01/2022 - 02/2012
6Opioid Analgesics (Opioids)IBA
01/2022 - 01/2013
6Glucose (Dextrose)FDA LinkGeneric
12/2020 - 01/2017
6Long Noncoding RNAIBA
07/2020 - 01/2017
5Mechanistic Target of Rapamycin Complex 2IBA
10/2015 - 08/2012
4Contrast MediaIBA
06/2022 - 12/2013
4CollagenIBA
06/2022 - 02/2013
4ChromatinIBA
10/2021 - 01/2020
4AntibodiesIBA
10/2021 - 11/2020
4Progesterone Receptors (Progesterone Receptor)IBA
08/2021 - 04/2015
4MelatoninIBA
06/2021 - 01/2019
4Colistin (Coly-Mycin)FDA Link
03/2021 - 12/2017
4Lidocaine (Xylocaine)FDA LinkGeneric
01/2021 - 01/2016

Therapy/Procedure

98Therapeutics
09/2022 - 02/2003
23Drug Therapy (Chemotherapy)
01/2022 - 12/2010
22Lasers (Laser)
06/2022 - 12/2011
19Photochemotherapy (Photodynamic Therapy)
01/2021 - 03/2015
16Immunotherapy
01/2022 - 01/2018
14Kidney Transplantation
03/2019 - 06/2009
13Photothermal Therapy
01/2021 - 02/2016
12Precision Medicine
01/2022 - 05/2015
12Transplantation
12/2021 - 06/2009
7Phototherapy (Light Therapy)
09/2022 - 03/2017
7Radiotherapy
03/2020 - 10/2010
6Microspheres (Microsphere)
05/2015 - 02/2012
5Anesthesia
01/2022 - 02/2007
5Nanospheres
03/2016 - 02/2013
4Conduction Anesthesia (Regional Anesthesia)
01/2022 - 01/2013